Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: myometrium

Results 1 - 45 of 45
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) myometrium - 726470
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase myometrium HSDB1 transcript abundance in the endometrium and myometrium remain at the same level during the examined days of pregnancy. After luteolysis both endometrial and myometrial HSD3B1 expression wane 725807
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase myometrium - 661605
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase myometrium in pregnant myometrium, PGI2, PGD2 and PGF2 synthases are highly expressed while prostaglandin dehydrogenase is underexpressed. Myometrium from non-pregnant women has lower levels of prostaglandin synthases and higher levels of prostaglandin dehydrogenase than pregnant myometrium 713047
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase myometrium PGH2 9-,11-endoperoxide reductase activity is expressed and active at early pregnant sows, probably also in cyclic sows 657328
Show all pathways known for 1.1.1.49Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.49glucose-6-phosphate dehydrogenase (NADP+) myometrium in patients with type 1 diabetes G6PDH activity does not differ from control group, but enzyme activity is sharply decreased in pregnant women with type 2 diabetes and gestational diabetes 696152
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase myometrium moderate expression 685803
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.B4011beta-hydroxysteroid dehydrogenase (NAD+) myometrium - 656372
Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.39nitric-oxide synthase (NADPH) myometrium three isoforms of nitric oxide synthase are mainly localized in the uterine luminal and glandular epithelium and myometrium, and the intensity of immunostaining for inducible nitric oxide synthase and endothelial nitric oxide synthase increases gradually with temporal development of the postnatal uterus. The total nitric oxide synthase and inducible nitric oxide synthase activities are significantly increased at postnatal days 21 and 35. Although constitutive nitric oxide synthase activity is increased at postnatal day 21, it decreases subsequently at postnatal day 35. Inducible nitric oxide synthase protein expression is significantly increased at postnatal days 21 and 35 723884
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1prostaglandin-endoperoxide synthase myometrium - 438395
Display the word mapDisplay the reaction diagram Show all sequences 1.3.99.63-oxo-5beta-steroid 4-dehydrogenase myometrium relative expression decreases significantly in association with labour by about 10fold 676039
Display the word mapDisplay the reaction diagram Show all sequences 1.6.3.1NAD(P)H oxidase (H2O2-forming) myometrium NADPH oxidase mediates angiotensin II-stimulated protein synthesis downstream of the type 1 receptor AT1 in myometrium smooth muscle cells 696573
Show all pathways known for 2.1.1.28Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.28phenylethanolamine N-methyltransferase myometrium low activity 639444
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.6catechol O-methyltransferase myometrium levels of staining for the COMT protein in myometrium are highest on day 1 and lowest on days 8 and 13, but high levels returned by days 16 and 19 of pregnancy. Modulation of COMT activity may play a role in the regulation of myometrial contractility and cervical ripening during pregnancy 690007
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.6catechol O-methyltransferase myometrium modulation of COMT activity may play a role in the regulation of myometrial contractility and cervical ripening during pregnancy 690007
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.154phosphatidylinositol-4-phosphate 3-kinase myometrium moderate expression of PI3K-C2alpha 645046
Show all pathways known for 2.7.1.91Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.91sphingosine kinase myometrium - 671224
Show all pathways known for 2.7.1.91Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.91sphingosine kinase myometrium during gestation, isoforms Sphk1 and Sphk2 are co-expressed. The levels and activity of SphK1/2 are modest at midgestation , increase at day 19 and progressively decline to low at postpartum. Inhibition of protein kinase C and ERK reduces SphK1/2 activity. In primary cultures of myometrial cells from day 19 pregnant rats, induction of COX2 is mediated by 4-phorbol 12,13-dibutyrate and IL-1 through sequential activation of protein kinase C, ERK1/2, and SphK1. Sphingosine 1-phosphate produced by SphK1 is released in the medium. In day 12 myometrial tissues, the release of sphingosine 1-phosphate is markedly reduced in association with low levels of SphK1 and COX2 703466
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.16G-protein-coupled receptor kinase myometrium primary cells 661600
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.18myosin-light-chain kinase myometrium - 640627, 640632
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.18myosin-light-chain kinase myometrium pregnant sheep myometrium, turkey and chicken gizzard enzyme are immunologically related 640626
Display the word mapDisplay the reaction diagram Show all sequences 2.7.8.29L-serine-phosphatidylethanolamine phosphatidyltransferase myometrium high level of expression 717766
Show all pathways known for 2.8.1.2Display the word mapDisplay the reaction diagram Show all sequences 2.8.1.23-mercaptopyruvate sulfurtransferase myometrium - 645559
Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.471-alkyl-2-acetylglycerophosphocholine esterase myometrium at least 2 isozymes I and II 650505
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.9glucose-6-phosphatase myometrium - 134945
Show all pathways known for 3.1.4.17Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.173',5'-cyclic-nucleotide phosphodiesterase myometrium myometrial cell, level of isoform PDE1C decreases in all conditions that inhibit proliferation 667433
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.353',5'-cyclic-GMP phosphodiesterase myometrium - 667433
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.353',5'-cyclic-GMP phosphodiesterase myometrium myometrial cell, level of isoform PDE5 decreases in all conditions that inhibit proliferation 667433
Display the word mapDisplay the reaction diagram Show all sequences 3.1.4.353',5'-cyclic-GMP phosphodiesterase myometrium pregnant and non-pregnant 670025
Display the word mapDisplay the reaction diagram Show all sequences 3.4.14.2dipeptidyl-peptidase II myometrium smooth muscle cells 650796
Display the word mapDisplay the reaction diagram Show all sequences 3.4.14.4dipeptidyl-peptidase III myometrium - 683562
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.5cathepsin D myometrium - 36917
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.24gelatinase A myometrium derived from premenopausal women aged 45-55 years who underwent total abdominal hysterectomy 683507
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.61nardilysin myometrium - 695465
Show all pathways known for 3.5.3.1Display the word mapDisplay the reaction diagram Show all sequences 3.5.3.1arginase myometrium significant decrease of enzyme activity during 7th-21st day of gestation, significant increase in enzyme activity at term gestation, day 22. Gestational changes in enzyme activity negatively correlate with those in cyclic GMP production and positively correlate with those in endogenous NO synthase inhibitors and endothelin-1 contents. Enhanced enzyme activity at term gestation may be implicated in increasing myometrial contractions mediated by increase in endothelin-1 670290
Show all pathways known for 4.4.1.1Display the word mapDisplay the reaction diagram Show all sequences 4.4.1.1cystathionine gamma-lyase myometrium pregnant myometrium, primarily localized to smooth muscle cells of pregnant myometrium 716719
Show all pathways known for 5.3.3.1Display the word mapDisplay the reaction diagram Show all sequences 5.3.3.1steroid DELTA-isomerase myometrium - 725807
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium - 661310, 747232
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium expressed to a lesser extent 661310
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium intermediate abundance of the protein 661605
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium isoform mPGES-1 localizes mostly in myometrial and vascular smooth muscle cells of pregnant women. Isoform cPGES is diffusely located throughout the myometrium. Expression of COX-2 and isoform mPGES-1 mRNA with term labour, whereas cPGES expression does not change. Interleukin 1beta stimulates release of prostaglandin E2 by myometrical smooth muscle cells and increases COX-2 and mPGES-1 mRNA and protein expression 681963
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium isoform mPGES-2 protein is largely in stromal cells surrounding smooth vascular muscle. Expression of mPGES-2 mRNA increases with term labour and preterm labour 681963
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase myometrium myometrial smooth muscle cell 679515
Display the word mapDisplay the reaction diagram Show all sequences 5.6.1.8myosin ATPase myometrium - 751639
Display the word mapDisplay the reaction diagram Show all sequences 7.2.2.10P-type Ca2+ transporter myometrium - 210480
Results 1 - 45 of 45
download as CSV
download all results as CSV